ESR1 and breast carcinoma: Analysis also showed DOT1L expression levels are significantly correlated with estrogen receptor negative (ER−) breast cancers (Supplementary Fig. 3A), although a smaller proportion of ER+ breast cancers still express relatively high levels of DOT1L.